Work

POSTER: ALL-712 Can Chimeric Antigen Receptor T-Cell Therapy Be a Definitive Treatment for Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Without Stem Cell Transplant? Long-Term Findings and Predictors of Sustained Remission for Obecabtagene Autoleucel

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)00429-x

Authors: Jae H. Park, Claire Roddie, Eleni Tholouli, Karamjeet S. Sandhu, Paul Shaughnessy, Pere Barba, Manuel Guerreiro, Deborah Yallop, Aaron C. Logan, Mehrdad Abedi, Pierre Lao-Sirieix, Yiyun Zhang, Wolfram Brugger, Bijal D. Shah, Michael R. Bishop, Daniel J. DeAngelo, Karl Peggs, Elias Jabbour

Institutions: Memorial Sloan Kettering Cancer Center, University College London, Manchester Royal Infirmary, City Of Hope National Medical Center, Methodist Healthcare, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Hospital Universitari i Politècnic La Fe, King's College Hospital NHS Foundation Trust, University of California, San Francisco, University of California, Davis, Autolus (United Kingdom), Moffitt Cancer Center, University of Chicago, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413781444

FWCI:

Cites:

Cited by:

Related to: 10